COVID-19 Vaccination Border Region Partnership Read more about COVID-19 Vaccination Border Region Partnership
Arizona State Opioid Response - Support Overdose Fatality Review Program Read more about Arizona State Opioid Response - Support Overdose Fatality Review Program
Anchor Biorepository, Sample Shipping and Handling, and Datafile Generation Read more about Anchor Biorepository, Sample Shipping and Handling, and Datafile Generation
Arizona Geriatrics Workforce Enhancement Program Read more about Arizona Geriatrics Workforce Enhancement Program
Visualization of the STN and GPi for DBS Surgery in Patients with Parkinson's Disease: VISION Study Read more about Visualization of the STN and GPi for DBS Surgery in Patients with Parkinson's Disease: VISION Study
KEVLARx: A Randomized Placebo-Controlled Trial of Two Schedules of RRx-001 for the Attenuation of Severe Oral Mucositis in Patients Receiving Concomitant Chemoradiation for the Treatment of Locally Ad Read more about KEVLARx: A Randomized Placebo-Controlled Trial of Two Schedules of RRx-001 for the Attenuation of Severe Oral Mucositis in Patients Receiving Concomitant Chemoradiation for the Treatment of Locally Ad
Dermal Allograft Augmentation of Large and Massive Rotator Cuff Tears Read more about Dermal Allograft Augmentation of Large and Massive Rotator Cuff Tears
Conform Pivotal Study: An Evaluation of the Safety and Effectiveness of the Conformal Left Atrial Appendage Seal (CLAAS) for Left Atrial Appendage Occlusion} Read more about Conform Pivotal Study: An Evaluation of the Safety and Effectiveness of the Conformal Left Atrial Appendage Seal (CLAAS) for Left Atrial Appendage Occlusion}
AdvanTIG-211: A Randomized, Double-blind, Placebo-controlled, Phase II Study Evaluating the Efficacy and Safety of Ociperlimab (WCD118) Combined With Tislelizumab (VDT482) Plus Chemotherapy Versus Pla Read more about AdvanTIG-211: A Randomized, Double-blind, Placebo-controlled, Phase II Study Evaluating the Efficacy and Safety of Ociperlimab (WCD118) Combined With Tislelizumab (VDT482) Plus Chemotherapy Versus Pla
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GLPG3667 in Adult Subject Read more about A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GLPG3667 in Adult Subject
